The NHS has launched a new device in England designed to accelerate the diagnosis of atrial fibrillation (AF), the most common arrhythmia and a contributing factor of up to one in five strokes in the UK. - News - PharmaTimes
A look at how tapping real world evidence from medical devices and patients could be a game changer, improving patient-clinician communication, supporting earlier interventions and helping patients manage their condition.
Innovative approaches to real world evidence collection present opportunities for medical device companies to improve patient outcomes. But success will depend on improving the way medtech companies integrate digital health. Executives from Abbott, Smith & Nephew, AliveCor and Huma weigh in on these issues.
MOUNTAIN VIEW, Calif., Sept. 28, 2022 /PRNewswire/ AliveCor, the leading innovator in personal electrocardiogram (ECG) technology, today announced a new integration partnership with health